II. Protocol: Brief Intervention for Problem Drinking
- See Chemical Dependency Brief Counseling
- Track patient progress
- Metrics for the last month
- Number of Alcohol free days
- Number of heavy drinking days
- Maximum number of drinks in one day
- Lab markers
- Biomarkers of Alcohol Use
- Other markers
- Serum Gamma glutamyl transferase (GGT)
- Carbohydrate deficient Transferrin
- Metrics for the last month
III. Protocol: Alcohol Use Disorder
- Initial Management
- Long-Term Abstinence Programs (12 step programs appear most effective)
- Alcoholics Anonymous
- Sponsor
- Treatment Program
- Halfway House
- Adjunctive Medications for abstinence
- General
- High relapse rate after 3 months
- Best evidence is for Naltrexone and Topiramate
- Consider Naltrexone with either Campral or Topiramate (generics for all are available)
- First line
- Naltrexone (Vivitrol, Revia)
- Blocks Opioid receptors
- Decreases pleasure from Alcohol
- Effective in reducing Alcohol use in non-abstaining patients
- Prevents relapse in one in 20 patients with 3 months of use
- Dosing
- Oral: 50 mg orally daily ($50/month in 2019)
- IM: Vivitrol once monthly IM ($1500/month in 2019)
- Effective in short-term, but not in long-term
- Campral (Acamprosate)
- Balances GABA and glutamate Neurotransmitters
- Reduces anxiety from abstinence (with better efficacy in abstinence than Naltrexone)
- May prevent relapse in one in 12 patients with 3-6 months of use
- Dosing: 2 tabs orally three times daily ($200/month in 2019)
- Risk of lower complicance due to a very large tablet taken 3 times daily
- Naltrexone (Vivitrol, Revia)
- Second line agents to consider
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Consider especially if comorbid depression
- Prozac often used, but other SSRIs effective
- Naranjo (2001) J Clin Psychiatry 62:18-25 [PubMed]
- Topiramate (Topamax)
- Decreases Alcohol use severity and heavy, binge drinking
- Improves abstinence, well being, quality of life in Alcoholics
- Requires dose titration
- Johnson (2004) Arch Gen Psychiatry 61:905-12 [PubMed]
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Other medications that may be effective
- Gabapentin (Neurontin) or Pregabalin (Lyrica)
- Risk of misuse, especially with Opioids
- Ondanestron
- Gabapentin (Neurontin) or Pregabalin (Lyrica)
- Agents to avoid
- Baclofen (insufficient evidence)
- Disulfiram (Antabuse)
- Taken 250 to 500 mg orally daily
- Not recommended due to risk and uncertain benefit
- General
IV. Resources
- See Chemical Dependency Resources
- See Alcoholism for Alcohol specific resources
V. Precautions
- Vitamin Deficiency is common (Vitamins A, C, B1, B3, B6, B9, B12)
-
Major Depression is common in recovering Alcoholics
- Treating Depression may lower risk of relapse
- Hasin (2002) Arch Gen Psychiatry 59:794-800 [PubMed]
VI. References
- (2019) Presc Lett 26(2): 11
- Sarmiento (Oct 2000) Federal Practitioner, p.45-50
- Enoch (2002) Am Fam Physician 65(3):441-50 [PubMed]
- Fleming (1997) JAMA 277:1039-45 [PubMed]
- Willenbring (2009) Am Fam Physician 80(1): 44-50 [PubMed]
- Winslow (2016) Am Fam Physician 93(6): 457-65 [PubMed]